Project: European Patients' Academy on Therapeutic Innovation (EUPATI)
Educating patients and the public about research and development of medicines
If you would like to see more projects like this please donate using the button above
The European Patients' Academy on Therapeutic Innovation (EUPATI) project is aiming to educate patients and the public about the research and development of medicines.
Currently, the development of treatments and medicines is a highly regulated, costly and complex process which is largely unknown to the public.
EUPATI aims to:
- develop and disseminate accessible, well structured and user-friendly information and education on the research and development of medicines;
- build competencies among well informed patients and the public about pharmaceutical research and development;
- build expert capacity in patient advocates;
- create the leading public library on patient information in six European languages, which are commonly used, under public licensing;
- establish a widely used, sustainable infrastructure for objective, credible, correct and up-to-date knowledge;
- facilitate patient involvement in research and development to support industry academia, authorities and ethics committees.
The project is working across twelve countries in the European Union (EU) and will provide scientifically reliable, objective, comprehensive information to patients on pharmaceutical R&D. It will increase the capacity of well-informed patients to be effective advocates and advisors. A consortium of 29 organisations, led by the European Patients' Forum, comprises a unique combination of pan-European patient organisations, academic and not-for profit organisations expert in patient and public engagement and EFPIA member companies. It features excellence in state-of-the art, high quality, objective education to patients about therapeutic innovation.
EUPATI will make a substantial and measurable difference to patients, providing the tools and the knowledge for their meaningful involvement and empowerment in pharmaceutical innovation, safety of medicines and access to treatments. It will inform the lay and hard to reach patient community, raising public awareness of the development of new treatments.
If you would like more information about the project please contact Amy on 020 7704 3141 or at